Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Fundamental Analysis

USA - NASDAQ:ICU - US81256L2034 - Common Stock

0.5949 USD
-0.02 (-3.08%)
Last: 10/27/2025, 8:27:30 PM
0.6093 USD
+0.01 (+2.42%)
After Hours: 10/27/2025, 8:27:30 PM
Fundamental Rating

3

ICU gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of ICU is average, but there are quite some concerns on its profitability. ICU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ICU has reported negative net income.
ICU had a negative operating cash flow in the past year.
In the past 5 years ICU always reported negative net income.
ICU had a negative operating cash flow in each of the past 5 years.
ICU Yearly Net Income VS EBIT VS OCF VS FCFICU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -175.01%, ICU is doing worse than 90.48% of the companies in the same industry.
With a Return On Equity value of -439.12%, ICU is not doing good in the industry: 83.07% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -175.01%
ROE -439.12%
ROIC N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICU Yearly ROA, ROE, ROICICU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

ICU's Gross Margin of 96.48% is amongst the best of the industry. ICU outperforms 100.00% of its industry peers.
ICU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICU Yearly Profit, Operating, Gross MarginsICU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

ICU has more shares outstanding than it did 1 year ago.
ICU has a better debt/assets ratio than last year.
ICU Yearly Shares OutstandingICU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ICU Yearly Total Debt VS Total AssetsICU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

ICU has an Altman-Z score of -27.14. This is a bad value and indicates that ICU is not financially healthy and even has some risk of bankruptcy.
ICU has a worse Altman-Z score (-27.14) than 91.53% of its industry peers.
ICU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -27.14
ROIC/WACCN/A
WACCN/A
ICU Yearly LT Debt VS Equity VS FCFICU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

A Current Ratio of 1.52 indicates that ICU should not have too much problems paying its short term obligations.
ICU has a Current ratio of 1.52. This is in the lower half of the industry: ICU underperforms 74.07% of its industry peers.
A Quick Ratio of 1.50 indicates that ICU should not have too much problems paying its short term obligations.
ICU has a Quick ratio of 1.50. This is in the lower half of the industry: ICU underperforms 60.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.5
ICU Yearly Current Assets VS Current LiabilitesICU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.08% over the past year.
EPS 1Y (TTM)87.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 39.34% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 203.56% on average over the next years. This is a very strong growth
EPS Next Y90.65%
EPS Next 2Y39.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year464.08%
Revenue Next 2Y203.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 500K 1M 1.5M 2M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ICU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICU Price Earnings VS Forward Price EarningsICU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICU Per share dataICU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

ICU's earnings are expected to grow with 39.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.34%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (10/27/2025, 8:27:30 PM)

After market: 0.6093 +0.01 (+2.42%)

0.5949

-0.02 (-3.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11
Inst Owners1.73%
Inst Owner Change13.17%
Ins Owners0.95%
Ins Owner Change1.32%
Market Cap20.29M
Revenue(TTM)766.00K
Net Income(TTM)-14671000
Analysts80
Price Target2.04 (242.91%)
Short Float %6.88%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.39%
Min EPS beat(2)16.22%
Max EPS beat(2)58.55%
EPS beat(4)3
Avg EPS beat(4)19.57%
Min EPS beat(4)-0.12%
Max EPS beat(4)58.55%
EPS beat(8)4
Avg EPS beat(8)-3.7%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)80.36%
Min Revenue beat(2)67.33%
Max Revenue beat(2)93.4%
Revenue beat(4)2
Avg Revenue beat(4)23.68%
Min Revenue beat(4)-55.78%
Max Revenue beat(4)93.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-71.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)59.46%
EPS NY rev (1m)6.49%
EPS NY rev (3m)53.55%
Revenue NQ rev (1m)-16.67%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-7.52%
Revenue NY rev (3m)7.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.48
P/FCF N/A
P/OCF N/A
P/B 6.07
P/tB 6.07
EV/EBITDA N/A
EPS(TTM)-2.62
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.02
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -175.01%
ROE -439.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.48%
FCFM N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.5
Altman-Z -27.14
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.52%
EPS Next Y90.65%
EPS Next 2Y39.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year464.08%
Revenue Next 2Y203.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.92%
OCF growth 3YN/A
OCF growth 5YN/A

SEASTAR MEDICAL HOLDING CORP / ICU FAQ

Can you provide the ChartMill fundamental rating for SEASTAR MEDICAL HOLDING CORP?

ChartMill assigns a fundamental rating of 3 / 10 to ICU.


What is the valuation status of SEASTAR MEDICAL HOLDING CORP (ICU) stock?

ChartMill assigns a valuation rating of 1 / 10 to SEASTAR MEDICAL HOLDING CORP (ICU). This can be considered as Overvalued.


How profitable is SEASTAR MEDICAL HOLDING CORP (ICU) stock?

SEASTAR MEDICAL HOLDING CORP (ICU) has a profitability rating of 1 / 10.


What is the earnings growth outlook for SEASTAR MEDICAL HOLDING CORP?

The Earnings per Share (EPS) of SEASTAR MEDICAL HOLDING CORP (ICU) is expected to grow by 90.65% in the next year.